Literature DB >> 16418593

Deletion of chromosome 21 disturbs human brain morphogenesis.

Guimei Yao1, Xiao-Ning Chen, Laura Flores-Sarnat, Gillian M Barlow, Giandomenico Palka, John B Moeschler, Barbara McGillivray, Richard P Morse, Julie R Korenberg.   

Abstract

PURPOSE: Humans with small deletions of chromosome 21 provide important models for understanding the role of dosage-sensitive genes in brain morphogenesis. To identify chromosome 21 genes responsible for defects of the central nervous system, we determined the deleted regions and brain malformations in three unrelated individuals with overlapping partial deletions of chromosome 21.
METHODS: Fluorescent in situ hybridization and magnetic resonance imaging were used to define the chromosomal structure and structural brain abnormalities present in these three individuals.
RESULTS: The regions of chromosome 21 found to be deleted in these individuals were as follows: case 1: KCNJ6 to the telomere; case 2: ITSN1 to the telomere; and case 3: ITSN1 to PCNT2. The abnormalities of brain structure shared by all included microcephaly, pachygyria, polymicrogyria, colpocephaly, hypoplastic corpus callosum and white matter, hypoplastic cerebellum, and enlarged ventricular system. The clinical features in common included mental retardation, microcephaly, facial dysmorphism, and epilepsy (severe in one patient).
CONCLUSION: From analyses of the molecular, cytogenetic, and neuroimaging data from these three individuals, combined with those from previously reported cases, we infer that deletion of an 8.4-Mb region in chromosome band 21q22.2-22.3 (KCNJ6-COL6A2) is associated with cortical dysplasia. We propose that one or more dosage-sensitive genes in this region contributes to cortical development and that deletion of 21q22.2-22.3 should be considered in the diagnosis of mentally retarded patients with facial dysmorphism and cerebral dysplasia.

Entities:  

Mesh:

Year:  2006        PMID: 16418593     DOI: 10.1097/01.gim.0000195892.60506.3f

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  12 in total

1.  Distinctive Phenotypic Abnormalities Associated with Submicroscopic 21q22 Deletion Including DYRK1A.

Authors:  R Oegema; A de Klein; A J Verkerk; R Schot; B Dumee; H Douben; B Eussen; L Dubbel; P J Poddighe; I van der Laar; W B Dobyns; P J van der Spek; M H Lequin; I F M de Coo; M-C Y de Wit; M W Wessels; G M S Mancini
Journal:  Mol Syndromol       Date:  2010-09-14

Review 2.  DNA damage responses in neural cells: Focus on the telomere.

Authors:  P Zhang; C Dilley; M P Mattson
Journal:  Neuroscience       Date:  2007-01-04       Impact factor: 3.590

3.  Consistent chromosome abnormalities identify novel polymicrogyria loci in 1p36.3, 2p16.1-p23.1, 4q21.21-q22.1, 6q26-q27, and 21q2.

Authors:  William B Dobyns; Ghayda Mirzaa; Susan L Christian; Kristin Petras; Jessica Roseberry; Gary D Clark; Cynthia J R Curry; Donna McDonald-McGinn; Livija Medne; Elaine Zackai; Julie Parsons; Dina J Zand; Fuki M Hisama; Christopher A Walsh; Richard J Leventer; Christa L Martin; Marzena Gajecka; Lisa G Shaffer
Journal:  Am J Med Genet A       Date:  2008-07-01       Impact factor: 2.802

4.  Genomic analysis of partial 21q monosomies with variable phenotypes.

Authors:  Elisha D O Roberson; Elizabeth Squibb Wohler; Julie E Hoover-Fong; Emily Lisi; Eric L Stevens; George H Thomas; Jay Leonard; Ada Hamosh; Jonathan Pevsner
Journal:  Eur J Hum Genet       Date:  2010-09-08       Impact factor: 4.246

5.  G Protein-Gated K+ Channel Ablation in Forebrain Pyramidal Neurons Selectively Impairs Fear Learning.

Authors:  Nicole C Victoria; Ezequiel Marron Fernandez de Velasco; Olga Ostrovskaya; Stefania Metzger; Zhilian Xia; Lydia Kotecki; Michael A Benneyworth; Anastasia N Zink; Kirill A Martemyanov; Kevin Wickman
Journal:  Biol Psychiatry       Date:  2015-11-10       Impact factor: 13.382

6.  Conflicting results of prenatal FISH with different probes for Down's Syndrome critical regions associated with mosaicism for a de novo del(21)(q22) characterised by molecular karyotyping: Case report.

Authors:  Christel Eckmann-Scholz; Stefan Gesk; Inga Nagel; Andrea Haake; Susanne Bens; Simone Heidemann; Monika Kautza; Christian Timke; Reiner Siebert; Almuth Caliebe
Journal:  Mol Cytogenet       Date:  2010-09-05       Impact factor: 2.009

7.  Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21q.

Authors:  Marwan Shinawi; Ayelet Erez; Deborah L Shardy; Brendan Lee; Rizwan Naeem; George Weissenberger; A Craig Chinault; Sau Wai Cheung; Sharon E Plon
Journal:  Blood       Date:  2008-05-16       Impact factor: 22.113

8.  Suppression of pyramidal neuron G protein-gated inwardly rectifying K+ channel signaling impairs prelimbic cortical function and underlies stress-induced deficits in cognitive flexibility in male, but not female, mice.

Authors:  Eden M Anderson; Steven Loke; Benjamin Wrucke; Annabel Engelhardt; Skyler Demis; Kevin O'Reilly; Evan Hess; Kevin Wickman; Matthew C Hearing
Journal:  Neuropsychopharmacology       Date:  2021-06-23       Impact factor: 7.853

Review 9.  Emerging roles for intersectin (ITSN) in regulating signaling and disease pathways.

Authors:  Michael P Hunter; Angela Russo; John P O'Bryan
Journal:  Int J Mol Sci       Date:  2013-04-10       Impact factor: 5.923

10.  Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A).

Authors:  Glòria Arqué; Vassiliki Fotaki; David Fernández; María Martínez de Lagrán; Maria L Arbonés; Mara Dierssen
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.